Abstract
Adalimumab, a Novel Anti‐Tumor Necrosis Factor‐α Antibody in a Child with Refractory Crohn's Disease
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have